Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 17, 2024 15:12 ET | Source: Starton Therapeutics

Starton Therapeutics Announces STARTICLES Filing

STARTICLES, referring to proprietary and novel solid-state particulates suspended within a drug-in-adhesive patch for delivery of active pharmaceutical ingredients (API) developed by Starton...
January 17, 2024 10:02 ET | Source: Northann Corp.

Northann Corp. Receives Approval from U.S. Patent and Trademark Office for Core Technology in Benchwick 3D Printing Ecosystem

Elk Grove, CA, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Northann Corp. (the “Company”) (NYSE American: NCL), a leading innovator in the field of 3D printing, today announced that it has received approval...
January 17, 2024 06:00 ET | Source: MediciNova, Inc.

MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China

LA JOLLA, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange...
January 16, 2024 09:00 ET | Source: Atsign

Atsign Revolutionizes Secure Data Exchange with Groundbreaking atProtocol® Patent Award

Atsign® announces the grant of US Patent No. 11,849,053-B2 for the atProtocol.
January 16, 2024 08:00 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

GAITHERSBURG, Md., Jan. 16, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...
January 16, 2024 01:00 ET | Source: PolTREG S.A.

PolTREG receives US Patent Office Notice of Allowance for Treg cell therapy to treat Type-1 Diabetes

Gdańsk, Poland – 16 January 2024, 07:00 CET – PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company in Europe developing cell therapies for use in a wide...
January 11, 2024 08:00 ET | Source: NEO Battery Materials Ltd.

NEO Battery Materials Files 9th Silicon Anode Patent for Major Manufacturing Innovation

TORONTO, Jan. 11, 2024 (GLOBE NEWSWIRE) -- January 11, 2024 – (TSXV: NBM) (OTCQB: NBMFF) Files 9th Patent Regarding Major Silicon Anode Manufacturing InnovationAdditives Employed to Prevent...
January 11, 2024 07:00 ET | Source: Algernon Pharmaceuticals

Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis

VANCOUVER, British Columbia, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage...
January 10, 2024 04:00 ET | Source: InterDigital, Inc.

InterDigital renews license agreements with Panasonic Entertainment & Communication Co., Ltd.

WILMINGTON, Del., Jan. 10, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, today announced that the company has renewed...
January 09, 2024 09:30 ET | Source: SOHM, Inc.

SOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations

CHINO HILLS, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures...